HMGB1 and cancer: A study has discovered a highly trustworthy HMGB1 protein structure model in mice, which could facilitate the docking and prediction of anticancer drugs, such as CGA conformers, that bind to the active target site of HMGB1, potentially leading to the development of a universal anticancer drug effective against various cancer types (7).